BridgeBio Pharma (BBIO) Stock Price, Quote, News & History | Benzinga

BridgeBio Pharma Inc (BBIO) Stock Price, Quote, News & History

BBIONASDAQ

Trade with Public

Trade with Public

$82.98

3.093.87%

At close: Aug 17, 5:00 PM EST

$82.98

3.093.87%

Pre-Market: 4:22 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

$82.98

Volume / Avg.

0 / 3.30M

Day Range

- - -

52 Wk Range

46.81 - 93.42

Market Cap

$16.22B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

62

Short Interest

13.33%

Days to Cover

11.5

Recent BridgeBio Pharma, Inc. News

Earnings Volatility Watch: Applied Materials and 10 Other Stocks Could See Double-Digit Moves This Week

Applied Materials, Coherent, CoreWeave and eight other names carry double-digit implied earnings moves in the second week of August. Here is what to watch.

Piero Cingari

Keysight To Rally Over 24%? Here Are 10 Top Analyst Forecasts For Monday

Wall Street analysts change outlook on top names. Complete view of analyst rating changes including upgrades/downgrades. See analyst ratings page.

Avi Kapoor

Ionis, AstraZeneca Stumble in ATTR-CM Trial as Rivals Stand to Gain

Ionis and AstraZeneca's Phase 3 ATTR-CM trial misses its primary goal, analyst says the outcome favors existing and next-gen therapies.

Vandana Singh

Aehr Test Systems, Lam Research, Applied Materials And Other Big Stocks Moving Higher On Thursday

U.S. stocks higher, Nasdaq up 150+ points. Aehr Test Systems shares rose 13.6%. Other big gainers include FBRX, BBIO, TRAX, LASR, ONTO, ALNY, ICHR, LITE, ARM, LRCX, KLAC, and FORM.

Avi Kapoor

Why Ultra Clean Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket

Stocks moving: RPGL +54.5%, EDBL +42.5%, SDOT +27.4%, BJDX +24.6%, AP +19.9%, SUNE +18%, ALNY +15.3%, AIBZ +14.3%, BBIO +10%. Losers: AFJK -25.8%, VTAK -19%, APVO -18%, NQ -16.3%.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-434.37M

Investing Cash Flow (TTM)

-34.74M

Financing Cash Flow (TTM)

398.05M

Free Cash Flow (TTM)

-437.79M

Capital Expenditure (TTM)

-3.42M

Net Change in Cash (TTM)

-71.06M

Analyst Trends and Forecast

5

Apr

4

2

May

2

Jun

1

1

Jul

8

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$18.00B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

22.58

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-4.29%

Earnings Yield % (FWD)

-2.58%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$12.87

Company Debt

Total Debt

$2.48B

LT Debt

$1.93B

LT Debt Issuance (TTM)

$632.50M

LT Debt Repayment (TTM)

$0

Total Cash

$677.91M

Debt to Equity

-

Issuance of Debt (TTM)

$632.50M

Repayment of Debt (TTM)

$0

Key Statistics

Open

-

Close

$82.98

Volume / Avg.

0 / 3.30M

Day Range

- - -

52 Wk Range

46.81 - 93.42

Market Cap

$16.22B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

62

Short Interest

13.33%

Days to Cover

11.5

About

Sector

Health Care

Industry

Biotechnology

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disor...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy BridgeBio Pharma (BBIO) stock?

A

You can purchase shares of BridgeBio Pharma (NASDAQ:BBIO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are BridgeBio Pharma (BBIO) competitors?

A

Other companies in BridgeBio Pharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for BridgeBio Pharma (BBIO) stock?

A

BridgeBio Pharma has a consensus price target of $90.89.

Q

What is the current price for BridgeBio Pharma (BBIO)?

A

The stock price for BridgeBio Pharma (NASDAQ: BBIO) is $82.98 last updated August 18, 2026 at 4:00 PM EDT.

Q

Does BridgeBio Pharma (BBIO) pay a dividend?

A

There are no upcoming dividends for BridgeBio Pharma.

Q

When is BridgeBio Pharma (NASDAQ:BBIO) reporting earnings?

A

BridgeBio Pharma does not have any upcoming earnings scheduled.

Q

Is BridgeBio Pharma (BBIO) going to split?

A

There is no upcoming split for BridgeBio Pharma.

Q

What sector and industry does BridgeBio Pharma (BBIO) operate in?

A

BridgeBio Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.